Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
JEOL Ltd. ( (JP:6951) ) has provided an announcement.
JEOL Ltd. has announced a strategic move to transfer its medical equipment business to a newly established subsidiary, which will then be acquired by Sysmex Corporation. This decision aims to leverage Sysmex’s strong industry presence and resources to drive sustainable growth and enhance JEOL’s corporate value through synergies in research, development, and business expansion.
The most recent analyst rating on (JP:6951) stock is a Buy with a Yen5332.00 price target. To see the full list of analyst forecasts on JEOL Ltd. stock, see the JP:6951 Stock Forecast page.
More about JEOL Ltd.
JEOL Ltd. operates in the scientific and metrology instruments sector, industrial equipment, and medical equipment business. The company is known for its automated clinical chemistry analyzers, which have been instrumental in advancing medical care and health maintenance.
Average Trading Volume: 258,580
Technical Sentiment Signal: Hold
Current Market Cap: Yen239B
For detailed information about 6951 stock, go to TipRanks’ Stock Analysis page.